What We're Reading: Page 255
Industry reads hand-picked by our editors
May 24, 2018
May 23, 2018
-
Bloomberg
Gene therapies that could transform diseases get easier FDA path
-
Chemical & Engineering News
$50 million more for CARB-X will help biotech companies fight antibiotic resistance
-
Los Angeles Times
New 'unified theory' of childhood leukemia raises possibility of preventing the disease
-
Associated Press
Many cancer patients juggle care along with financial pain
May 22, 2018
-
The New York Times
New cancer treatments lie hidden under mountains of paperwork
-
San Francisco Business Times
'Bursting at the seams,' this high-profile Peninsula biotech company is moving to a bigger home
-
Bloomberg
Deadly Chinese Fentanyl Is Creating a New Era of Drug Kingpins
May 21, 2018
May 18, 2018
May 17, 2018
-
NPR
How a drugmaker gamed the system to keep generic competition away
-
Mother Jones
A promising new Ebola vaccine is about to be put to the test
-
Vox
100 million Americans have chronic pain. Very few use one of the best tools to treat it.
-
HealthNewsReview.org
ASCO 2018: How a major medical meeting uses embargoes to shape the news, and what the consequences may be